Different market share values for TBE vaccines in Austria are reported during the period 2018–2020. However, both data likely cover a significant under-estimation of doses distributed. Thus, for epidemiological evaluations, market share should be used with prudence and only reported when solid whole-market market share can be validated and referenced.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282088 | PMC |
http://dx.doi.org/10.1093/jtm/taac027 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!